- Home
- FSEA vs ECOR Comparison
FSEA vs ECOR Comparison
Compare FSEA & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSEA
- ECOR
- Stock Information
- Founded
- FSEA 1890
- ECOR 2005
- Country
- FSEA United States
- ECOR United States
- Employees
- FSEA N/A
- ECOR N/A
- Industry
- FSEA Savings Institutions
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FSEA Finance
- ECOR Health Care
- Exchange
- FSEA Nasdaq
- ECOR Nasdaq
- Market Cap
- FSEA 51.2M
- ECOR 57.5M
- IPO Year
- FSEA N/A
- ECOR 2018
- Fundamental
- Price
- FSEA $11.65
- ECOR $6.69
- Analyst Decision
- FSEA
- ECOR Strong Buy
- Analyst Count
- FSEA 0
- ECOR 2
- Target Price
- FSEA N/A
- ECOR $25.50
- AVG Volume (30 Days)
- FSEA 7.6K
- ECOR 216.5K
- Earning Date
- FSEA 03-21-2025
- ECOR 03-12-2025
- Dividend Yield
- FSEA N/A
- ECOR N/A
- EPS Growth
- FSEA N/A
- ECOR N/A
- EPS
- FSEA N/A
- ECOR N/A
- Revenue
- FSEA $15,874,000.00
- ECOR $25,182,000.00
- Revenue This Year
- FSEA N/A
- ECOR $40.88
- Revenue Next Year
- FSEA N/A
- ECOR $48.01
- P/E Ratio
- FSEA N/A
- ECOR N/A
- Revenue Growth
- FSEA 70.41
- ECOR 57.09
- 52 Week Low
- FSEA $8.25
- ECOR $5.32
- 52 Week High
- FSEA $11.65
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- FSEA 74.99
- ECOR 19.00
- Support Level
- FSEA $11.32
- ECOR $6.57
- Resistance Level
- FSEA $11.45
- ECOR $8.25
- Average True Range (ATR)
- FSEA 0.14
- ECOR 0.92
- MACD
- FSEA 0.02
- ECOR -0.15
- Stochastic Oscillator
- FSEA 100.00
- ECOR 4.82
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities and bank-owned life insurance.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.